Portage Biotech Total Current Liabilities

Portage Biotech (PRTG) currently reports a total current liabilities of $1.1M as of March 2025. That compares with $2.9M in the prior-year period — down 61.8% year over year. Use the charts on this page to explore Portage Biotech's total current liabilities history and peer comparisons.

Portage Biotech's total current liabilities decreased from $2.9M to $1.1M — a 61.8% year-over-year decrease (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Portage Biotech reported $1.1M in total current liabilities as of March 2025. That compares with $2.9M in the prior-year period — down 61.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $1.1M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Portage Biotech, and consider following PRTG for alerts when major investors trade the stock.

Portage Biotech is classified in the Energy sector. On total current liabilities, it currently shows $1.1M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Energy are usually more informative than comparing PRTG with unrelated industries.